Axtria, a global cloud software and data analytics provider that helps life sciences businesses bring therapeutics to the market faster, said that it is expanding its business operations in India. Axtria recently received a $150 million growth investment from Bain Capital Tech Opportunities. A part of the capital will be infused into India operations to consolidate its position in cloud software and artificial intelligence (AI) space and strengthen its suite of life sciences focused SaaS platforms.
Commenting on the latest developments at Axtria, Jaswinder Chadha, Co-founder and CEO, Axtria, said, “India continues to remain a key business operations centre for Axtria. Over 75 percent of our employees are currently based out of India and we are set to add another 1,000-1,500 new recruits to our workforce in the next couple of years. With the latest round of funding, we will be doubling down on our commitment to make the life sciences industry future-ready with further investments in our SaaS products. AI and Machine Learning driven advanced analytics will be embedded across all levels, allowing companies to engage their customers through omnichannel strategies.”
The company said in a statement, “The latest round of funding will enable and strengthen Axtria’s efforts on helping life sciences companies bring therapeutic drugs to market faster and efficiently through SaaS platforms, data driven digital transformation, and AI enabled analytics. The company will be significantly ramping up its recruitment process to expand its workforce with the right skill sets, especially in the STEM segment to cater to the growing and diverse needs of the Life Sciences and Health Care industry. Axtria will be recruiting 1,000-1500 people in the next couple of years.”
Observing the growth potential of the Life Sciences industry and explaining Axtria’s role in it, Manish Mittal, Principal, India, said, “Axtria’s mission-critical solutions have a significant positive impact on millions of patients and drug developers. Our products and solutions are designed to help life sciences businesses bring therapeutic drugs to the market faster. This, in fact, reduces the time taken for a new drug to reach the right patient. Axtria’s innovative and data driven solutions to the most complex problems facing the Life Sciences Industry will help our customers scale their global commercial operations and connect with patients more efficiently.”
“Over the years, we have made significant investments to develop life sciences-focused software platforms that significantly improve strategic and day-to-day global operations. With this new investment, Axtria will further solidify its leadership position of enterprise products that help customers drive better patient outcomes globally,” added Mr. Chadha.
Arya has been a part of the Content & Research Team at Hrnxt.com. She is a keen observer of economic developments, emerging businesses, people in business and keeps a tab on latest happenings in the business environment.